Third of UK consumers "don't read PILs"
One-third of UK consumers polled in a recent survey said that they donot bother to read the patient information leaflet accompanying their medicines. This means they may be unaware of side effects and possible complications, according to the Moss Pharmacy chain, which carried out the survey.
In addition, nearly one-quarter of men polled admitted that they have taken another person's medication, and 18% of all respondents said that they had recommended their own prescribed medicines to family or friends.
17% said that they ignore use-by dates on a medicine before taking it, and over 50% admitted that they kept their medication in warm steamy kitchens or bathrooms, which can adversely affect some medicines' effectiveness.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze